Dear colleagues and friends,
The XXXIInd International Workshop on Helicobacter and Microbiota in Inflammation and Cancer will be held in Innsbruck, Austria, September 5 - 7, 2019.
I herewith cordially invite you to actively participate in this event.
I hope that you will have a stimulating and fruitful meeting and that you will enjoy Austria.
See you in Innsbruck in September 2019!
Prof. Dr. Herbert Tilg
President of the European Helicobacter and Microbiota Study Group
Dear colleagues and friends,
The XXXIInd International Workshop on Helicobacter and Microbiota in Inflammation and Cancer will be held in Innsbruck, Austria, September 5 - 7, 2019.
I herewith cordially invite you to actively participate in this event.
I hope that you will have a stimulating and fruitful meeting and that you will enjoy Austria.
See you in Innsbruck in September 2019!
Prof. Dr. Herbert Tilg
President of the European Helicobacter and Microbiota Study Group
European Helicobacter and Microbiota Study Group
Lars ENGSTRAND
​
Karolinska Institutet
Postal address:
SE-171 77 Stockholm Visiting address:
Solnavägen 1, Solna
Alfred Nobels Allé 8, Huddinge
phone +46 8-524 800 00
fax +46 8-31 11 01
Short CV:
Professor Lars Engstrand at the Karolinska Institutet, Stockholm has more than 25 years experience as a clinical microbiologist. His research interest includes the pathophysiology, diagnosis and treatment of gastrointestinal infections and studies on cellular interactions and pathogenesis particularly in the context of Helicobacter pylori infections. In a number of studies, population-based epidemiology has been combined with clinical and basic microbiological science, including molecular biology and genetics. Similar approaches have been applied on studies of the human microbiota in health and disease.
Professor Engstrand has contributed to the Helicobacter field for 25 years and has published 140 scientific papers and book chapters on various aspects of this infection (out of 200). He has initiated the use of new diagnostic tools in clinical microbiology such as the next generation sequencing technology i.e. 454 pyrosequencing.
Cross-departmental collaborations have been developed with a number research centers in Europe and USA. Prof. Engstrand has currently faculty positions at the Department of Medicine, Baylor College of Medicine, Houston, Tx and at Washington University, School of Medicine. St. Louis. Since 2012 he is Director of clinical omics at Science for Life Laboratory in Stockholm.
